منابع مشابه
Medical comorbidity in schizophrenia.
The extent and consequences of medical comorbidity in patients with schizophrenia are generally underrecognized. Patients with comorbid conditions are usually excluded from research studies, although they probably represent the majority of individuals with schizophrenia. Elderly patients are especially likely to have comorbid disorders. In this article, we review selected literature on medical ...
متن کاملMedical comorbidity in schizophrenia.
Schizophrenia has been described as a "life-shortening disease", and physical comorbidity accounts for 60% of premature deaths not related to suicide. People with schizophrenia and other mental illnesses have a higher rate of preventable risk factors such as smoking, high alcohol consumption, poor diet, and lack of exercise. Recognition and management of morbidity in people with mental illness ...
متن کاملPhysical comorbidity in schizophrenia & its correlates
The presence of common physical comorbidities, their demographic and clinical correlates and impact on functioning was assessed in 100 patients with schizophrenia. The patients had a mean age of 35.12±10.7 yr with mean duration of illness of 8.3±0.58 years. Seventy per cent were detected to have a comorbid physical condition. Common conditions included hypertension (21%), diabetes mellitus (15%...
متن کاملMetabolic Challenges in Schizophrenia
Schizophrenia is a psychiatric disorder requiring constant vigilance and lifelong intervention with psycho therapeutic counseling and administration of Antipsychotic drugs. Metabolic aberrations are documented to occur more frequently in subjects with Schizophrenia (SCH) prior to treatment and the prevalence of these metabolic alterations is significantly raised following administration of Anti...
متن کاملManaging the comorbidity of schizophrenia and ADHD.
A 19-year-old man was referred from the children’s hospital for ongoing follow-up at an adult early intervention psychosis service. Despite 2 years of treatment for schizophrenia, his outcome has been poor owing to poor medication adherence and recurrent substance abuse. At age 16 he started treatment with stimulants for suspected attention-deficit/hyperactivity disorder (ADHD). Owing to concer...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Medical Sciences
سال: 2008
ISSN: 0019-5359
DOI: 10.4103/0019-5359.38920